| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0006-3223(00)00961-6 |
| P698 | PubMed publication ID | 11018226 |
| P50 | author | Susan L McElroy | Q56816544 |
| Paul E. Keck | Q111738411 | ||
| P2860 | cites work | Treatment of social phobia with gabapentin: a placebo-controlled study | Q33420919 |
| Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project. | Q33654229 | ||
| Risperidone treatment for juvenile bipolar disorder: a retrospective chart review | Q33703978 | ||
| The pharmacologic basis of antiepileptic drug action | Q33775706 | ||
| A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 | ||
| Placebo-controlled study of gabapentin treatment of panic disorder | Q33845115 | ||
| Placebo effect in randomized, controlled studies of acute bipolar mania and depression | Q33895456 | ||
| A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders | Q33927263 | ||
| Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan | Q34052877 | ||
| Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study | Q34221866 | ||
| Open-label adjunctive topiramate in the treatment of bipolar disorders. | Q34509360 | ||
| Valproate in the treatment of acute mania. A placebo-controlled study | Q34613045 | ||
| Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 | ||
| Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. | Q34744028 | ||
| Mood stabilizer combinations: a review of safety and efficacy | Q34744469 | ||
| Anticonvulsants in the treatment of bipolar disorder | Q35469813 | ||
| The treatment of manic psychoses by the administration of lithium salts | Q37273969 | ||
| Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study | Q39709837 | ||
| Drug treatment of mania: a critical review | Q40850874 | ||
| Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics | Q40851029 | ||
| Treatment of acute bipolar depression: a review of the literature | Q40954013 | ||
| Update on the mechanism of action of antiepileptic drugs | Q41240609 | ||
| A summary of mechanistic hypotheses of gabapentin pharmacology | Q41743616 | ||
| Induction of mania by risperidone resistant to mood stabilizers | Q42551501 | ||
| Manic symptoms associated with initiation of risperidone | Q42554423 | ||
| Clozapine in the treatment of refractory psychotic mania | Q42627098 | ||
| Olanzapine in treatment-resistant bipolar disorder | Q42678439 | ||
| Efficacy of lithium as acute treatment of manic-depressive illness | Q43647019 | ||
| A double-blind comparison of valproate and lithium in the treatment of acute mania | Q44975667 | ||
| Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects | Q44993702 | ||
| Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group | Q45338046 | ||
| Olanzapine compared to lithium in mania: a double-blind randomized controlled trial | Q46146139 | ||
| Use of topiramate, a new anti-epileptic as a mood stabilizer | Q48777380 | ||
| Clinical predictors of acute response with olanzapine in psychotic mood disorders. | Q50904498 | ||
| Depression during mania. Treatment response to lithium or divalproex. | Q50978467 | ||
| The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. | Q51103177 | ||
| Risperidone treatment of bipolar disorder. | Q51106565 | ||
| Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy. | Q51115148 | ||
| Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. | Q52900826 | ||
| Gabapentin in the acute treatment of refractory bipolar disorder. | Q53895639 | ||
| Response to clozapine in acute mania is more rapid than that of chlorpromazine. | Q53972337 | ||
| The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. | Q54027554 | ||
| Quetiapine for treatment-resistant mania. | Q54043314 | ||
| Letter: How blind is the double-blind?: an assessment in a lithium-prophylaxis study. | Q54334212 | ||
| Clinical Factors in Lithium Carbonate Prophylaxis Failure | Q54507329 | ||
| Treatment of Refractory Rapid Cycling Bipolar Disorder With Risperidone | Q57612984 | ||
| Adjunctive Use of Olanzapine in Mood Disorders: Five Case Reports | Q58185825 | ||
| Tiagabine Appears Not to Be Efficacious in the Treatment of Acute Mania | Q61764441 | ||
| The efficacy of lamotrigine in rapid cycling and non–rapid cycling patients with bipolar disorder | Q63446703 | ||
| Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol | Q66891830 | ||
| The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders | Q67299383 | ||
| Carbamazepine compared with lithium in the treatment of mania | Q68027502 | ||
| Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients | Q68264296 | ||
| Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol | Q69518665 | ||
| Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: An interim report | Q69864633 | ||
| A Double-Blind Comparison of Lithium and Chlorpromazine in the Treatment of Manic States | Q69897530 | ||
| Correlates of antimanic response to carbamazepine | Q69902133 | ||
| A Comparison of Lithium Carbonate and Chlorpromazine in Mania | Q69916677 | ||
| Comparative Effects of Lithium and Chlorpromazine in the Treatment of Acute Manic States | Q69943203 | ||
| Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study | Q70321034 | ||
| A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania | Q70539313 | ||
| Respiridone and mania | Q70834953 | ||
| Clozapine for treatment-refractory mania | Q71085936 | ||
| Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder | Q71640270 | ||
| Risperidone in HIV-related manic psychosis | Q71652092 | ||
| Re: Hypomania associated with risperidone | Q71676902 | ||
| The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine | Q71705251 | ||
| Clinical experience with risperidone | Q71706984 | ||
| Effects of carbamazepine and lithium on affective disorders | Q72586329 | ||
| Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association | Q72850842 | ||
| Treatment of acute mania with gabapentin | Q73030591 | ||
| Gabapentin in the treatment of bipolar disorder | Q73030603 | ||
| Acute treatment of bipolar disorder with adjunctive risperidone in outpatients | Q73148526 | ||
| Pharmacologic loading in the treatment of acute mania | Q73628833 | ||
| Topiramate as add-on treatment for patients with bipolar mania | Q73634791 | ||
| Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group | Q73688073 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 539-557 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Pharmacologic agents for the treatment of acute bipolar mania. | |
| P478 | volume | 48 |
| Q61886048 | A History of the Pharmacological Treatment of Bipolar Disorder |
| Q38496254 | A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia. |
| Q36649096 | Acute treatment of mania: an update on new medications |
| Q44804255 | Adjunct treatments in acute mania |
| Q42682051 | An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients |
| Q34553398 | Anticonvulsants and antipsychotics in the treatment of bipolar disorder |
| Q46886132 | Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study |
| Q35094691 | Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic |
| Q45063190 | Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study |
| Q40644004 | Atypical antipsychotics in the therapy of bipolar disorders: efficacy and safety |
| Q33448290 | Bipolar disorder. |
| Q30784001 | Boundaries of schizophrenia |
| Q37165441 | Carbamazepine extended-release capsules in bipolar disorder. |
| Q36257188 | Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder |
| Q38556588 | Changing Trends in Treatment of Acute Mania: Experience of a Tertiary Centre Over a Decade |
| Q40661158 | Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders |
| Q35142745 | Combination treatment in bipolar disorder: a review of controlled trials |
| Q34387550 | Comparative efficacy and tolerability of drug treatments for bipolar disorder |
| Q34578345 | Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. |
| Q39390893 | Convergent effects of lithium and valproate on the expression of proteins associated with large dense core vesicles in NGF-differentiated PC12 cells. |
| Q42510974 | Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D(2)-like receptors. |
| Q46984808 | Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials |
| Q33821029 | Family treatment for bipolar disorder: family impairment by treatment interactions |
| Q24245158 | Haloperidol alone or in combination for acute mania |
| Q24248855 | Haloperidol alone or in combination for acute mania |
| Q36099541 | Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder |
| Q30652740 | Lateral hypothalamic kindling induces manic-like behavior in rats: a novel animal model |
| Q92206076 | Mania in elderly people |
| Q36119897 | Mood stabilization in the treatment of bipolar disorder: focus on quetiapine |
| Q35219695 | Naturalistic evaluation of inpatient treatment of mania in a private Brazilian psychiatric hospital |
| Q24241099 | Olanzapine in long-term treatment for bipolar disorder |
| Q24250116 | Olanzapine in long-term treatment for bipolar disorder |
| Q80397920 | Oxcarbazepine versus Divalproex Sodium for the Continuing Treatment of Mania |
| Q34295980 | Parsing pediatric bipolar disorder from its associated comorbidity with the disruptive behavior disorders |
| Q34508138 | Pharmacologic treatment of geriatric mania |
| Q36634438 | Pharmacological interventions for bipolar youth: developmental considerations |
| Q36909255 | Pharmacotherapeutic strategies for pediatric bipolar disorder |
| Q35124708 | Pharmacotherapy of first-episode psychosis |
| Q30462823 | Predictive animal models of mania: hits, misses and future directions |
| Q39853694 | Psychiatric Uses of Newer Anticonvulsants |
| Q36648780 | Psychopharmacology of pediatric bipolar disorder: a review |
| Q62868812 | Psychotropic effects of antiepileptic drugs |
| Q36316977 | Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder |
| Q44957587 | Response to clozapine of rapid cycling versus non-cycling patients with a history of mania |
| Q35884680 | Rethinking the treatment paradigm for bipolar depression: the importance of long-term management |
| Q45011556 | Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder |
| Q33755661 | Role of extended release quetiapine in the management of bipolar disorders |
| Q35940851 | Safety considerations in pharmacotherapy of bipolar disorder |
| Q34116326 | The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues |
| Q46944730 | The interaction between dopamine D2-like and beta-adrenergic receptors in the prefrontal cortex is altered by mood-stabilizing agents. |
| Q36128822 | The management of bipolar disorder in primary care: a review of existing and emerging therapies |
| Q37076060 | The neuropharmacology of psychosis |
| Q42690598 | Tiagabine in treatment refractory bipolar disorder: a clinical case series. |
| Q35673093 | Treatment of acute mania |
| Q35613758 | Treatment of non-schizophrenic disorders: focus on atypical antipsychotics |
| Q40498082 | Uses of Newer Anticonvulsants: An Update |
| Q44261478 | Zonisamide treatment of bipolar disorder: a case report |
Search more.